Silver

Silver

SCHEMBL333097

[Ag+].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPK1 P28482 2/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
TSHR P16473 4/20 0.33
TDP1 Q9NUW8 3/20 0.33
LMNA P02545 3/20 0.33
MAPT P10636 3/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CA12 O43570 1/20 0.33
GLA P06280 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA14 Q9ULX7 1/20 0.33
ALOX12 P18054 1/20 0.33
ACHE P22303 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Silver SCHEMBL7514944 0.96 ALDH1A1 (0.44) ALDH1A1MAPK1RAB9ANPC1TSHR
SCHEMBL143876 0.96 ALDH1A1 (0.50) ALDH1A1MAPK1RAB9ANPC1TSHR
SCHEMBL11707018 0.96 ALDH1A1 (0.50) ALDH1A1MAPK1RAB9ANPC1TSHR
Benzene SCHEMBL31091106 0.96 ALDH1A1 (0.50) ALDH1A1MAPK1RAB9ANPC1TSHR
Phosphine SCHEMBL9242100 0.92 ALDH1A1 (0.47) ALDH1A1MAPK1RAB9ANPC1TSHR
SCHEMBL225363 0.92 ALDH1A1 (0.47) ALDH1A1MAPK1RAB9ANPC1TSHR
Ammonia Solution, Strong SCHEMBL234555 0.92 ALDH1A1 (0.47) ALDH1A1MAPK1RAB9ANPC1TSHR
Ammonia Solution, Strong SCHEMBL8002765 0.92 ALDH1A1 (0.47) ALDH1A1MAPK1RAB9ANPC1TSHR
SCHEMBL1132217 0.92 ALDH1A1 (0.47) ALDH1A1MAPK1RAB9ANPC1TSHR
Potassium Ion SCHEMBL134847 0.92 ALDH1A1 (0.47) ALDH1A1MAPK1RAB9ANPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 546 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111548483-B Use of Salen manganese complexes in tandem catalytic reactions involving unsaturated anhydride-epoxy copolymers 中国科学技术大学 2021-08-13 CN claimed
CN-111548483-A Use of Salen manganese complexes in tandem catalytic reactions involving unsaturated anhydride-epoxy copolymers 中国科学技术大学 2020-08-18 CN claimed
US-10308563-B2 Process for producing ethylene oligomers HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) 2019-06-04 US claimed
US-20180170827-A1 PROCESS FOR PRODUCING ETHYLENE OLIGOMERS HANWHA TOTALENERGIES PETROCHEMICAL CO., LTD. (KR) 2018-06-21 US claimed
US-20180169642-A1 CATALYST SYSTEM FOR ETHYLENE OLIGOMERIZATION AND METHOD FOR PRODUCING ETHYLENE OLIGOMERIZATION USING THE SAME HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) 2018-06-21 US claimed
US-9718898-B1 Homogeneous polymerization catalyst for alpha olefins LION COPOLYMER GEISMAR, LLC (US) 2017-08-01 US claimed
US-9718897-B1 Process for the polymerization or copolymerization of an alpha olefin LION COPOLYMER GEISMAR, LLC (US) 2017-08-01 US claimed
US-8975202-B2 Polymerization catalysts and method for preservation of same IDEMITSU KOSAN CO., LTD. (JP) 2015-03-10 US claimed
US-20120129683-A1 POLYMERIZATION CATALYSTS AND METHOD FOR PRESERVATION OF SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-24 US claimed
EP-1363955-B1 MULTINUCLEAR METALLOCENE CATALYST HONAM PETROCHEMICAL CORP (KR) 2008-04-09 EP claimed
US-6943225-B2 Multinuclear metallocene catalyst HONAM PETROCHEMICAL CORPORATION (KR) 2005-09-13 US claimed
EP-1046654-B1 Olefin polymerization catalysts and olefin polymer production methods using said olefin polymerization catalysts JSR CORP (JP) 2005-06-29 EP claimed
US-20040072677-A1 Multinuclear metallocene catalyst HONAM PETROCHEMICAL CORPORATION (KR) 2004-04-15 US claimed
EP-1363955-A1 MULTINUCLEAR METALLOCENE CATALYST Honam Petrochemical Corporation (KR) 2003-11-26 EP claimed
US-6525150-B1 Such as vanadium 2,2'-thiobis(6-t-butyl-4-methylphenyl) oxychloride complex, trimethylaluminum and N,N-dimethyl-anilinium tetrakis(pentafluorophenyl)borate; high degree of copolymerization JSR CORPORATION (JP) 2003-02-25 US claimed
WO-2002060964-A1 MULTINUCLEAR METALLOCENE CATALYST HONAM PETROCHEMICAL CORPORATION (KR) 2002-08-08 WO claimed
US-6169152-B1 COPOLYMER OF ETHYLENE AND A POLAR GROUP-CONTAINING CYCLIC OLEFIN COMPRISING ESTER- OR ANHYDRIDE MODIFIED NORBORNENE OR PERHYDRO-2,3-DIDEHYDRO-1,4:5,8-DIMETHANONAPHTHALENE MADE WITH CATALYST SUCH AS 1,5,9-TRIAZACYCLODODECANYLTITANIUM CHLORIDE JSR CORPORATION (JP) 2001-01-02 US claimed
EP-1046654-A1 Olefin polymerization catalysts and olefin polymer production methods using said olefin polymerization catalysts JSR Corporation (JP) 2000-10-25 EP claimed
US-6100352-A USING A CATALYST CONSISTING OF A TRANSITION METAL COMPOUND, A COMPOUND CAPABLE OF FORMING AN IONIC COMPOUND BY REACTING WITH THE TRANSITION METAL COMPOUND OR AN OXYGEN-CONTAINING COMPOUND SUCH AS ALUMINOXANE IDEMITSU KOSAN CO., LTD. (JP) 2000-08-08 US claimed
EP-0617277-A1 Ion-selective electrode and process for preparing the same HITACHI, LTD. (JP) 1994-09-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10308563-B2 Process for producing ethylene oligomers OXER1, HAO2, ORC3 ALDH1A1 1507/4885MAPK1 2584/4885RAB9A 3258/4885
US-20180169642-A1 CATALYST SYSTEM FOR ETHYLENE OLIGOMERIZATION AND METHOD FOR PRODUCING ETHYLENE OLIGOMERIZATION USING THE SAME HACL2, HAO2, MSMO1 ALDH1A1 1614/4885MAPK1 2501/4885RAB9A 3554/4885
US-20180170827-A1 PROCESS FOR PRODUCING ETHYLENE OLIGOMERS OXER1, HAO2, ORC3 ALDH1A1 1507/4885MAPK1 2584/4885RAB9A 3258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.